Aukst-Margeti, B., B. Margeti, G. Tosi, and A. Bili-Prci. 2004. Levomepromazine helps to reduce sleep problems in patients with PTSD. European Psychiatry: The Journal of the Association of European Psychiatrists 19(4):235-236.
Australia Centre for Posttraumatic Mental Health (ACPMH). 2007. Australian guidelines for the treatment of adults with acute stress disorder and posttraumatic stress disorder. Melbourne, Victoria: ACPMH.
Baker, D., B. Diamond, G. Gillette, M. Hamner, D. Katzelnick, T. Keller, T. Mellman, E. Pontius, M. Rosenthal, P. Tucker, B. van der Kolk, and R. Katz. 1995. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology 122(4):386-389.
Bartzokis, G., P. H. Lu, J. Turner, J. Mintz, and C. S. Saunders. 2004. Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biological Psychiatry 57(5):474-479.
Berlant, J. L. 2004. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder. BMC Psychiatry 4:24.
Berlant, J., and D. P. van Kammen. 2002. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: A preliminary report. Journal of Clinical Psychiatry 63(1):15-20.
Brady, K., T. Pearlstein, G. M. Asnis, D. Baker, B. Rothbaum, C. R. Sikes, and G. M. Farfel. 2000. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. Journal of the American Medical Association 283(14):1837-1844.
Brady, K. T., S. Sonne, R. F. Anton, C. L. Randall, S. E. Back, and K. Simpson. 2005. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcoholism: Clinical and Experimental Research 29(3):395-401.
Braun, P., D. Greenberg, H. Dasberg, and B. Lerer. 1990. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. Journal of Clinical Psychiatry 51(6):236-238.
Butterfield, M. I., M. E. Becker, K. M. Connor, S. Sutherland, L. E. Churchill, and J. R. Davidson. 2001. Olanzapine in the treatment of post-traumatic stress disorder: A pilot study. International Clinical Psychopharmacology 16(4):197-203.
Cates, M. E., M. H. Bishop, L. L. Davis, J. S. Lowe, and T. W. Woolley. 2004. Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Annals of Pharmacotherapy 38(9):1395-1399.
Chung, M. Y., K. H. Min, Y. J. Jun, S. S. Kim, W. C. Kim, and E. M. Jun. 2004. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: A randomized open label trial. Human Psychopharmacology 19(7):489-494.
Clark, R. D., J. M. Canive, L. A. Calais, C. R. Qualls, and V. B. Tuason. 1999. Divalproex in posttraumatic stress disorder: An open-label clinical trial. Journal of Traumatic Stress 12(2):395-401.
Connor, K. M., S. M. Sutherland, L. A. Tupler, M. L. Malik, and J. R. Davidson. 1999. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. British Journal of Psychiatry 175:17-22.
Connor, K. M., J. R. Davidson, R. H. Weisler, W. Zhang, and K. Abraham. 2006. Tiagabine for posttraumatic stress disorder: Effects of open-label and double-blind discontinuation treatment. Psychopharmacology 184(1):21-25.
Davidson, J. R. T. 2004. Remission in post-traumatic stress disorder (PTSD): Effects of sertraline as assessed by the Davidson Trauma Scale, clinical global impressions and the clinician-administered PTSD scale. International Clinical Psychopharmacology 19(2):85-87.